[Anthelmintic therapy with mebendazole in children with broncho-pulmonary infections (author's transl)].
The fact that the incidence of infection significantly increases in patients being a poor physical condition is commonly known. Especially in children a high rate of helminthic infection is to be expected as could be assessed by the present investigation. The easy diagnostic technique can now be combined with a highly effective new treatment, extremely well tolerated and devoid of side effects. Results obtained with the new polyvalent anthelmintic Mebendazole are described in the present study.
D000293:Adolescent; D001562:Benzimidazoles / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000150:complications; D002648:Child; D002675:Child, Preschool; D006373:Helminthiasis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use*; D011014:Pneumonia / Q000150:complications; D012140:Respiratory Tract Diseases / Q000150:complications*
D001562:Benzimidazoles; D008463:Mebendazole
Anthelmintika-Therapie mit Mebendazol bei Kindern mit broncho-pulmonalen Erkrankungen